Volume : 13, Issue : 11, November – 2026
Title:
EVALUATION OF ANALGESIC ACTIVITY OF METHANOL
A NOVEL SUSTAINED RELEASE DELIVERY SYSTEM FOR METHIMAZOLE: ENHANCING THERAPEUTIC EFFICACY AND PATIENT COMPLIANCE
Authors :
Jangiti Rekha, I.Nagaraju, Dr.K.Ramesh, G Vijaya Kumar
Abstract :
The present study aimed to develop a novel sustained release delivery system of Methimazole to enhance therapeutic efficacy and improve patient compliance by reducing the frequency of dosing. Methimazole is widely used in the management of Hyperthyroidism, but its conventional dosage forms require frequent administration due to rapid drug release. Therefore, the formulation of sustained release tablets was undertaken using natural and synthetic polymers to achieve controlled drug delivery.
In this study, sustained release tablets of methimazole were prepared using different concentrations and ratios of polymers such as Karaya Gum, Xanthan Gum, and Sodium Stearyl Fumarate. The prepared powder blends were evaluated for various pre-compression parameters including angle of repose, bulk density, tapped density, Carr’s index, and Hausner’s ratio to determine their flow properties. The compressed tablets were further evaluated for post-compression parameters such as hardness, thickness, friability, weight variation, and drug content uniformity.
All the evaluated pre-compression and post-compression parameters were found to be within the acceptable limits specified by the Indian Pharmacopoeia, indicating satisfactory flow characteristics, mechanical strength, and uniformity of the tablets. In-vitro dissolution studies were carried out for all formulations to evaluate the drug release pattern over a period of 12 hours. Among the developed formulations, formulation F6 exhibited a maximum cumulative drug release of 99.96% within 12 hours, demonstrating an effective sustained release profile. Hence, formulation F6 was considered the optimized formulation when compared to other formulations.
Keywords: Methimazole, Karaya Gum, Xanthan Gum, and Sodium Stearyl Fumarate.
Cite This Article:
Please cite this article in press Jangiti Rekha et al., A Novel Sustained Release Delivery System For Methimazole: Enhancing Therapeutic Efficacy And Patient Compliance.,. Indo Am. J. P. Sci, 2026; 13(11).
REFERENCES:
1. John C, Morten C. The Science of Dosage Form Design, Aulton: Modified release peroral dosage forms, Churchill Livingstone, 2, 2002, 290-300.
2. Brahmankar D M, Jaiswal S B. Biopharmaceutics and Pharmacokinetics Pharmacokinetics, Vallabh Prakashan, Delhi, 2(1), 2009, 399-401.
3. Lee V H L. Controlled Drug Delivery Fundamentals and Applications: Influence of drug properties on design, Marcel Dekker, Inc. New York, 2nd edition, 1987, 16-25.
4. Wani MS et al. Controlled Release System-A Review, 6(1), 2008.
5. Ho W H, Lee H L V. Sustained Drug Delivery Fundamentals and Applications: Design and fabrication of oral controlled release drug delivery system, Marcel Dekker Inc, New York: 2nd edition, 1987, 373-420.
6. Janos B, Klara P, Odon P, Geza R J, Rok D, Stane S, Istvan E. Film coating as a method to enhance the preparation of tablets from dimenhydrinate crystals, Int. J. Pharm. 269(2), 2004, 393-401.
7. Lachaman L, Liberman H A, Kanig J L. The theory and practice of industrial pharmacy. Varghese publishing house, 3rd edition, 1987, 23-28.
8. Higuchi T. Mechanism of sustained-action medication: Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J. Pharm Sci, 52(12), 1963, 1145-1149.
9. Venkataraman D S N, Chester A, Kliener L. An overview of controlled release system, Handbook of pharmaceutical controlled release technology, Marc dekker Inc, 2000, 1-30.
10. Jain N K. Controlled and novel drug delivery. CBS pub and distribution, 50(1), 1997, 1-25. 11. Mamidala R, Ramana V, Lingam M, Gannu R, Rao MY. Review article factors influencing the design and performance of oral sustained/controlled release dosage form, Int. journal of pharmaceutical science and nanotechnology. 2(3), 2009, 583.
12. Cristina M, Aranzazu Z, Jose ML. Review: Critical factors in the release of drugs from sustained release hydrophilic matrices, Int Journal of Research in Ayurveda and Pharmacy, 2(6), 2011, 1701.
13. Wise DL. Handbook of pharmaceutical controlled release technology. Marcel dekkerInc new York, 1, 2002, 432-460.
14. Jamzad S, Fassihi R. Development of controlled release low dose class II drug-glipizide, Int. J. Pharm, 312(1-2), 2006, 24-32.
15. Salsa T, Veiga F, Pina ME. Oral controlled release dosage form. Cellulose ether polymers in hydrophilic matrices. Drug Develop. & Ind. Pharm. 23(9), 1997, 929-938.
16. Sung KC, Nixon PR, Skoug JW. Effect of formulation variables on drug and polymer release from HPMC-based matrix tablets, Int. J. Pharm, 142(1), 1996, 53-60.
17. Basak S, Reddy J B, Mani L K. Formulation and release behaviour of sustained release ambroxol hydrochloride HPMC matrix tablet, Indian J. Pharm. Sci, 68(5), 2006, 594-598.
18. Lapidus H, Lordi N G. Studies on controlled release formulations, Journal of Pharmaceutical sciences, 57(8), 1968, 1292-1301.
19. Kamboj S, Gupta G D. Matrix Tablets: An important tool for oral controlled release dosage forms, Pharmainfo.net, 7(6), 2009, 1-9.
20. Vyas S P, Khar R K. Controlled Drug Delivery: Concepts and Advances. Vallabh Prakashan, 1st edition, 2002, 156-189.